NRF2 Activation by Nitrogen Heterocycles: A Review

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Molecular Biology

Background:

• Nitrogen heterocycles are prevalent in FDA-approved drugs, highlighting their importance in drug development.
• These compounds are known to activate the NRF2/ARE signaling pathway, influencing antioxidant and anti-inflammatory responses.
• NRF2-activating molecules are crucial for managing diseases linked to oxidative stress and neuroinflammation.

Purpose of the Study:

• To review the role of nitrogen heterocyclic moieties in activating the NRF2 signaling pathway.
• To discuss the pharmacological properties and structural-activity relationships of N-based heterocycles.
• To explore their therapeutic potential in various diseases, particularly those involving oxidative stress and inflammation.

Main Methods:

• Literature review focusing on NRF2 activation by nitrogen heterocycles.
• Analysis of pharmacological effects and structure-activity relationships.
• Synthesis of information on antioxidant and anti-inflammatory actions.

Main Results:

• Nitrogen heterocycles significantly activate the NRF2/ARE pathway, upregulating key genes like HO-1 and NQO1.
• These compounds demonstrate notable antioxidant and anti-inflammatory activities.
• The review consolidates existing knowledge on their therapeutic relevance.

Conclusions:

• Nitrogen heterocycles are promising scaffolds for NRF2-activating drugs.
• Understanding their mechanisms can lead to novel treatments for oxidative stress and inflammatory diseases.
• Further research into their pharmacological properties and SAR is warranted to stimulate innovative drug discovery.